33 related articles for article (PubMed ID: 2013446)
21. A phase I-II study with intraperitoneal cisplatin plus systemic etoposide in patients with minimal residual ovarian cancer.
Willemse PH; Sleijfer DT; de Vries EG; Boonstra H; Bouma J; Mulder NH
Eur J Cancer; 1992; 28(2-3):479-81. PubMed ID: 1591067
[TBL] [Abstract][Full Text] [Related]
22. Ovarian cancer.
Ozols RF; Young RC
Curr Probl Cancer; 1987; 11(2):57-122. PubMed ID: 3556023
[TBL] [Abstract][Full Text] [Related]
23. A phase I-II trial of intraperitoneal cisplatin and alpha-interferon in patients with persistent epithelial ovarian cancer.
Berek JS; Welander C; Schink JC; Grossberg H; Montz FJ; Zigelboim J
Gynecol Oncol; 1991 Mar; 40(3):237-43. PubMed ID: 2013446
[TBL] [Abstract][Full Text] [Related]
24. Gynecological malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
[TBL] [Abstract][Full Text] [Related]
25. Combined carboplatin and cisplatin. Limited prospects for dose intensification.
Waterhouse DM; Reynolds RK; Natale RB
Cancer; 1993 Jun; 71(12):4060-6. PubMed ID: 8508371
[TBL] [Abstract][Full Text] [Related]
26. A phase I study of intraperitoneal interferon-alpha 2b and intravenous cis-platinum plus cyclophosphamide chemotherapy in patients with untreated stage III epithelial ovarian cancer: a Gynecologic Oncology Group pilot study.
Moore DH; Valea F; Walton LA; Soper J; Clarke-Pearson D; Fowler WC
Gynecol Oncol; 1995 Nov; 59(2):267-72. PubMed ID: 7590485
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
Zanetta G; Fei F; Mangioni C
Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
[TBL] [Abstract][Full Text] [Related]
28. A review: intraperitoneal cisplatin in the management of patients with ovarian cancer.
McClay EF; Howell SB
Gynecol Oncol; 1990 Jan; 36(1):1-6. PubMed ID: 2403957
[TBL] [Abstract][Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]